You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Infliximab and adalimumab for the treatment of Crohn's disease

  • Technology appraisal guidance
  • Reference number: TA187
  • Published:  19 May 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Appendix A: Decision paper presented to the Institute's Guidance Executive

Appendix A: Decision paper presented to the Institute's Guidance Executive Appendix A: Decision paper presented to the Institute's Guidance Executive
07 March 2011
(95.55 Kb 27 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 07 March 2011

Back to top